Positron emission tomography (PET) for diagnosis and therapy management of malignant lymphomas;Die Positronenemissionstomographie (PET) bei der Diagnostik und Therapieplanung von malignen Lymphomen

Radiologe

Volumn 37, Issue 1, 1997, Pages 74-80

  Dimitrakopoulou Strauss, Antonia ^a   Strauss, L G ^a   Goldschmidt, H ^b   Hegenbart, U ^b   Irngartinger, G ^a   Oberdorfer, F ^a   Van Kaick, G ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

15O water; 18FDG; lymphomas; monitoring; positron emission tomography

Indexed keywords

CARMUSTINE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; MELPHALAN; WATER O 15;

CLINICAL ARTICLE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MALE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; REVIEW; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD GLUCOSE; COMBINED MODALITY THERAPY; DEOXYGLUCOSE; ENERGY METABOLISM; FLUORODEOXYGLUCOSE F18; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0031057747     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050179     Document Type: Review

References (19)

1. Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32: 623-648
2. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H et al. ( 1995) Evalua-tion of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 22: 434-442
3. Toorongian SA, Mulholland GK, Jewett DM et al. (1990) Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Nucl Med Biol 3: 273-279
4. Del Fiore F, Depresseux JC, Bartsch P et al. (1979) Production of oxygen-15, nitrogen-13 and carbon-11 and of their low molecular weight derivatives for biomedical applications. Int J Appl Radiat Isot 30:5443-549
5. Patlak CS and Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metabol 5: 584-590
6. Strauss LG, Clorius JH, Schlag P et al. (1989) Recurrence of colorectal tumors: PET evaluation. Radiology 170: 329-332
7. Eil A, Dimitrakopoulou-Strauss A, Tilgen W et al. (1996) Functional imaging with positron emission tomography in patients with malignant melanoma. Onkologie 19:253-259
8. Braams JW, Pruim J, Freling NJM et al. (1995) Detection of lymph node me tastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 36: 211-216
9. Bangerter M, Kocher F, Binder T et al. (1995) Total body positron emission tomography (PET) for staging and followup of lymphoma. Proc Ann Meet Am Soc Clin Oncol 14: 1206
10. Jabour BA, Choi Y, Hoh CK et al. (1993) Extracranial head and neck: PET imaging with 2-(F-18)fluoro-2deoxy-D-glucose and MR imaging correlation. Radiology 186: 27-35
11. Strauss EG (1996) Fluorine-18 deoxy-glucose and false-positive results: a major problem in the diagnostics of onco-logical patients. Eur J Nucl Med 23: 1409-1415
12. Kubota R, Yamada S, Kubota K et al. (1992) Intratumoral distribution of Fluorine-18-Fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33: 1972-1980
13. Okada J, Yoshikawa K, Itami M et al. (1992) Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. J Nucl Med 33:325-329
14. Higashi K, Clavo A, Wahl RL (1993) Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 34:414-419
15. Brown RS, Fisher SJ, Wahl RL (1993) Autoradiographic evaluation of the intratumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J Nucl Med 34: 75-82
16. Kubota K, Kubota R, Yamada S (1993) FDG accumulation in tumor tissue. J Nucl Med 34: 419-42
17. Longo DL (1990) The use of chemotherapy in the treatment of Hodgkin's disease. Semin Oncol 17: 716-735
18. Okada J, Yoshikawa K, Imazeki K et al. (1991) The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis. J Nucl Med 32: 686-691
19. Wylie BR, Southee AE, Joshua DE et al. (1989) Gallium scanning in the management of mediastinal Hodgkin's disease. Eur J Haematol 42: 344-347